Breast Cancer
-
Navelbine(Vinorelbine) – NSCLC | HongKong DengYue Medicine
-
Qingweishi (Everolimus) – Oncology | HongKong DengYue Medicine
-
Phesgo (Pertuzumab/Trastuzumab) – HER2-Positive | HongKong DengYue Medicine
-
Kropsen (Proxalutamide) – mCRPC | HongKong DengYue Medicine
-
Margenza (Margetuximab) – HER2 | HongKong DengYue Medicine
-
Verzenio (Abemaciclib) – Breast Cancer | HongKong DengYue Medicine
-
Rujianing (Lerociclib) – Breast Cancer | HongKong DengYue Medicine
-
Kangmeina (Tibremciclib) – Breast Cancer | HongKong DengYue Medicine
-
Futuoning (Fovinaciclib) – Breast Cancer | HongKong DengYue Medicine
-
Xuanyuening (Birociclib) – Breast Cancer | HongKong DengYue Medicine
-
Nerlynx (Neratinib) – HER2 | HongKong DengYue Medicine
-
TRODELVY (Sacituzumab Govitecan) – mTNBC | HongKong DengYue Medicine
-
Entinostat Tablets – HDAC | HongKong DengYue Medicine
-
ENHERTU (Trastuzumab Deruxtecan) – HER2-driven cancers | HongKong DengYue Medicine
-
Herceptin (Trastuzumab) – Breast Cancer | HongKong DengYue Medicine
-
Kisqali (Ribociclib) – Breast Cancer | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights